21709 results for «»
21709 results
MASTER-DAPT: “the MASTER of high-bleeding risk trials”
28 Aug 2021
Marco Valgimigli (Lugano, Switzerland) presented the results of the MASTER DAPT trial on Saturday, August 28, in a Hot Line session of the ESC Congress 2021. Luis G. Ortega-Paz provides his PICOT & SWOT analysis of this study.
Author
ESC/EACTS Valvular Heart Disease Guidelines 2021: updates from the 2017 Guidelines
29 Aug 2021
There has been significant expansion in the field of structural heart diseases in the last couple of years, generating an extensive body of evidence and warranting an update to the 2017 Guidelines. Mirvat Alasnag provides an analysis of the updates included in this new document - a joint...
Author
2021 ESC/EACTS Valvular Heart Disease Guidelines: interview with Alec Vahanian
29 Aug 2021
Mirvat Alasnag interviews Alec Vahanian on the Essentials of the 2021 ESC/EACTS Guidelines on Valvular Heart Diseases.
Author
Author
PCR London Valves 2026 registration: FAQs and information
Thin-cap fibroatheroma predicts clinical events in diabetic patients with normal fractional flow reserve: the COMBINE OCT–FFR trial
16 Aug 2021
The aim of this study was to understand the impact of optical coherence tomography (OCT)-detected thin-cap fibroatheroma (TCFA) on clinical outcomes of diabetes mellitus (DM) patients with fractional flow reserve (FFR)-negative lesions.
Reviewer
Reviewer
Reviewer
Tesfaye A. Telila
Atlanta, United States of America
Delayed compromise of a “super dominant” RCA and Shock
14 Sep 2021
Coronary obstruction is a known procedural complication of aortic valve replacement. However, delayed presentation few months after surgical AVR is a relatively unusual phenomenon. We describe a 75 year old woman with surgical AVR who presented with acute coronary syndrome and severe RV failure few months...
Author
#4 - How should I apply the Culotte technique in everyday practice?
17 Aug 2021
Discover the replay of this PCR Webinar on bifurcation with B. Chevalier, G. Toth and G. Stankovic
Jérôme Ferrara
Marseille, France
Ahmet Zengin
Istanbul, Türkiye
Antiplatelet therapy in patients with conservatively managed spontaneous coronary artery dissection from the multicentre DISCO registry
20 Aug 2021
The aims of this study were to assess the use of antiplatelet drugs in medically treated spontaneous coronary artery dissection (SCAD) patients and to investigate the relationship between single (SAPT) and dual (DAPT) antiplatelet regimens and 1-year patient outcomes.
Reviewer
Reviewer
Stent expansion indexes to predict clinical outcomes: an IVUS substudy from ADAPT-DES
23 Aug 2021
The purpose of the present investigation was to revisit all stent expansion indexes to identify the best predictor of 2-year percutaneous coronary intervention (PCI) lesion-specific outcome measures (i.e. clinically-driven target lesion revascularization [TLR] or definite stent thrombosis) using the ADAPT-DES IVUS substudy cohort.
Reviewer
Astin Lee
Wollongong, Australia
Fazila Malik
Dhaka, Bangladesh
Asad Pathan
KARACHI, Pakistan
Azhari Rosman
Kuala Lumpur, Malaysia
Iwo Slobodzianek
Toulouse, France
PCR Tokyo Valves 2021 – What's on?
Challenging Left Main Cases
18 May 2021 – From EuroPCR 2021
Watch this session to learn how to treat a challenging LM case in a young patient, to question the need to treat residual LAD disease after PPCI for an inferior STEMI, to find out more about complex left main bifurcation PCI with OCT control, and to...
MASTER DAPT: dual antiplatelet therapy after coronary stenting in high bleeding risk patients - interview with Marco Valgimigli
28 Aug 2021
ESC Congress 2021: Discover the interview given by Marco Valgimigli to Luis G. Ortega-Paz for PCRonline about the MASTER-DAPT trial to assess whether one month of dual antiplatelet therapy preserves the net and major adverse cardiovascular events.
Author
Author
